Human Genome Epidemiology Literature Finder
|
Records 1 - 19 (of 19 Records) |
| Query Trace: Ovarian Neoplasms and ABCB1[original query] |
|---|
| ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel. Journal of pharmaceutical sciences 2008 Jun 97 (6): 2045-8. Gréen Henrik, Söderkvist Peter, Rosenberg Per, Horvath György, Peterson Cu |
| Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Oct 25 (29): 4528-35. Marsh Sharon, Paul Jim, King Cristi R, Gifford Gillian, McLeod Howard L, Brown Robe |
| ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Sep 14 (17): 5594-601. Johnatty Sharon E, Beesley Jonathan, Paul Jim, Fereday Sian, Spurdle Amanda B, Webb Penelope M, Byth Karen, Marsh Sharon, McLeod Howard, , Harnett Paul R, Brown Robert, DeFazio Anna, Chenevix-Trench Georg |
| Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study. Gynecologic oncology 2009 May 113 (2): 264-9. Kim Hee Seung, Kim Mi-Kyung, Chung Hyun Hoon, Kim Jae Weon, Park Noh Hyun, Song Yong Sang, Kang Soon Be |
| Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer. Basic & clinical pharmacology & toxicology 2009 Feb 104 (2): 130-7. Gréen Henrik, Söderkvist Peter, Rosenberg Per, Mirghani Rajaa A, Rymark Per, Lundqvist Elisabeth Avall, Peterson Cu |
| Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer. The pharmacogenomics journal 2011 Apr 11 (2): 113-20. Bergmann T K, Brasch-Andersen C, Gréen H, Mirza M, Pedersen R S, Nielsen F, Skougaard K, Wihl J, Keldsen N, Damkier P, Friberg L E, Peterson C, Vach W, Karlsson M O, Brosen |
| Two multidrug-resistance (ABCB1) gene polymorphisms as prognostic parameters in women with ovarian cancer. Anticancer research 2010 Sep 30 (9): 3487-91. Grimm Christoph, Polterauer Stephan, Zeillinger Robert, Tong Dan, Heinze Georg, Wolf Andrea, Natter Camilla, Reinthaller Alexander, Hefler Lukas |
| Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. International journal of molecular epidemiology and genetics 2011 2 (2): 185-95. Peethambaram Prema, Fridley Brooke L, Vierkant Robert A, Larson Melissa C, Kalli Kimberly R, Elliott Elaine A, Oberg Ann L, White Kristin L, Rider David N, Keeney Gary L, Cunningham Julie M, Hartmann Lynn C, Goode Ellen |
| Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancer. Cancer chemotherapy and pharmacology 2011 Nov 68 (5): 1255-62. Zamboni William C, Combest Austin J, DeLoia Julie A, Edwards Robert P, Bridges Arlene S, Zamboni Beth A, Walko Christine M, Yu Angela Y C, Krivak Thomas C, Kelley Joseph |
| Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer. European journal of clinical pharmacology 2011 Jul 67 (7): 693-700. Bergmann Troels K, Gréen Henrik, Brasch-Andersen Charlotte, Mirza Mansoor R, Herrstedt Jørn, Hølund Berit, du Bois Andreas, Damkier Per, Vach Werner, Brosen Kim, Peterson Cu |
| Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancer. Basic & clinical pharmacology & toxicology 2012 Feb 110 (2): 199-204. Bergmann Troels K, Brasch-Andersen Charlotte, Gréen Henrik, Mirza Mansoor R, Skougaard Kristin, Wihl Jessica, Keldsen Nina, Damkier Per, Peterson Curt, Vach Werner, Brøsen K |
| ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecologic oncology 2013 Oct 131 (1): 8-14. Johnatty Sharon E, Beesley Jonathan, Gao Bo, Chen Xiaoqing, Lu Yi, Law Matthew H, Henderson Michelle J, Russell Amanda J, Hedditch Ellen L, Emmanuel Catherine, Fereday Sian, Webb Penelope M, , Goode Ellen L, Vierkant Robert A, Fridley Brooke L, Cunningham Julie M, Fasching Peter A, Beckmann Matthias W, Ekici Arif B, Hogdall Estrid, Kjaer Susanne K, Jensen Allan, Hogdall Claus, Brown Robert, Paul Jim, Lambrechts Sandrina, Despierre Evelyn, Vergote Ignace, Lester Jenny, Karlan Beth Y, Heitz Florian, du Bois Andreas, Harter Philipp, Schwaab Ira, Bean Yukie, Pejovic Tanja, Levine Douglas A, Goodman Marc T, Camey Michael E, Thompson Pamela J, Lurie Galina, Shildkraut Joellen, Berchuck Andrew, Terry Kathryn L, Cramer Daniel W, Norris Murray D, Haber Michelle, MacGregor Stuart, deFazio Anna, Chenevix-Trench Georg |
| Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 May 22 (5): 987-92. White Kristin L, Vierkant Robert A, Fogarty Zachary C, Charbonneau Bridget, Block Matthew S, Pharoah Paul D P, Chenevix-Trench Georgia, , Rossing Mary Anne, Cramer Daniel W, Pearce Celeste Leigh, Schildkraut Joellen M, Menon Usha, Kjaer Susanne Kruger, Levine Douglas A, Gronwald Jacek, Culver Hoda Anton, Whittemore Alice S, Karlan Beth Y, Lambrechts Diether, Wentzensen Nicolas, Kupryjanczyk Jolanta, Chang-Claude Jenny, Bandera Elisa V, Hogdall Estrid, Heitz Florian, Kaye Stanley B, Fasching Peter A, Campbell Ian, Goodman Marc T, Pejovic Tanja, Bean Yukie, Lurie Galina, Eccles Diana, Hein Alexander, Beckmann Matthias W, Ekici Arif B, Paul James, Brown Robert, Flanagan James M, Harter Philipp, du Bois Andreas, Schwaab Ira, Hogdall Claus K, Lundvall Lene, Olson Sara H, Orlow Irene, Paddock Lisa E, Rudolph Anja, Eilber Ursula, Dansonka-Mieszkowska Agnieszka, Rzepecka Iwona K, Ziolkowska-Seta Izabela, Brinton Louise, Yang Hannah, Garcia-Closas Montserrat, Despierre Evelyn, Lambrechts Sandrina, Vergote Ignace, Walsh Christine, Lester Jenny, Sieh Weiva, McGuire Valerie, Rothstein Joseph H, Ziogas Argyrios, Lubinski Jan, Cybulski Cezary, Menkiszak Janusz, Jensen Allan, Gayther Simon A, Ramus Susan J, Gentry-Maharaj Aleksandra, Berchuck Andrew, Wu Anna H, Pike Malcolm C, Van Denberg David, Terry Kathryn L, Vitonis Allison F, Doherty Jennifer A, Johnatty Sharon E, Defazio Anna, Song Honglin, Tyrer Jonathan, Sellers Thomas A, Phelan Catherine M, Kalli Kimberly R, Cunningham Julie M, Fridley Brooke L, Goode Ellen |
| Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC pharmacology & toxicology 2015 16 2. Lambrechts Sandrina, Lambrechts Diether, Despierre Evelyn, Van Nieuwenhuysen Els, Smeets Dominiek, Debruyne Philip R, Renard Vincent, Vroman Philippe, Luyten Daisy, Neven Patrick, Amant Frédéric, Leunen Karin, Vergote Ignace, |
| Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy. Journal of experimental & clinical cancer research : CR 2015 34 2. Tecza Karolina, Pamula-Pilat Jolanta, Kolosza Zofia, Radlak Natalia, Grzybowska E |
| ABCB1 Variation Affects Myelosuppression, Progression-free Survival and Overall Survival in Paclitaxel/Carboplatin-treated Ovarian Cancer Patients. Basic & clinical pharmacology & toxicology 2018 Mar . Björn Niclas, Jakobsen Falk Ingrid, Vergote Ignace, Gréen Henr |
| Polymorphisms of ABCB1, CYP3A4 and CYP3A5 Genes in Ovarian Cancer and Treatment Response in Poles. Anticancer research 2018 03 38 (3): 1455-1459. Fiszer-Maliszewska ?ucja, ?aczma?ski ?ukasz, Doli?ska Aneta, Jagas Maria, Ko?odziejska Ewelina, Jankowska Magdalena, Ku?nierczyk Pio |
| GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel-Based Chemotherapy in Ovarian Cancer. Clinical and translational science 2020 Dec . Ferracini Amanda Canato, Lopes-Aguiar Leisa, Lourenço Gustavo Jacob, Yoshida Adriana, Lima Carmen Silva Passos, Sarian Luis Otávio, Derchain Sophie, Kroetz Deanna L, Mazzola Priscila Ga |
| Toxicity and therapy outcome associations in LIG3, SLCO1B3, ABCB1, OPRM1 and GSTP1 in high-grade serous ovarian cancer. Basic & clinical pharmacology & toxicology 2023 3 . Deng Feng, Laasik Maren, Salminen Liina, Lapatto Lauri, Huhtinen Kaisa, Li Yilin, Hautaniemi Sampsa, Hynninen Johanna, Niemi Mikko, Lehtonen Rain |
- Page last reviewed:Feb 1, 2024
- Content source: